Operating Income (Loss) in USD of ABVC BIOPHARMA, INC. from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
ABVC BIOPHARMA, INC. quarterly/annual Operating Income (Loss) history and change rate from Q2 2010 to Q3 2025.
  • ABVC BIOPHARMA, INC. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$1.17M, a 286% decline year-over-year.
  • ABVC BIOPHARMA, INC. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$4.86M, a 7.72% decline year-over-year.
  • ABVC BIOPHARMA, INC. annual Operating Income (Loss) for 2024 was -$4.71M, a 30.5% increase from 2023.
  • ABVC BIOPHARMA, INC. annual Operating Income (Loss) for 2023 was -$6.77M, a 55.2% increase from 2022.
  • ABVC BIOPHARMA, INC. annual Operating Income (Loss) for 2022 was -$15.1M, a 29.1% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

ABVC BIOPHARMA, INC. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$4.86M -$1.17M -$866K -286% 01 Jul 2025 30 Sep 2025 10-Q 03 Nov 2025
Q2 2025 -$3.99M -$2.29M -$1.43M -167% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025
Q1 2025 -$2.56M -$693K +$2.15M +75.6% 01 Jan 2025 31 Mar 2025 10-Q 30 Apr 2025
Q4 2024 -$4.71M -$705K -$193K -37.7% 01 Oct 2024 31 Dec 2024 10-K 15 Apr 2025
Q3 2024 -$4.51M -$302K +$1.85M +86% 01 Jul 2024 30 Sep 2024 10-Q 03 Nov 2025
Q2 2024 -$6.37M -$860K +$1.33M +60.8% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025
Q1 2024 -$7.7M -$2.84M -$932K -48.9% 01 Jan 2024 31 Mar 2024 10-Q 30 Apr 2025
Q4 2023 -$6.77M -$512K +$2.62M +83.7% 01 Oct 2023 31 Dec 2023 10-K 15 Apr 2025
Q3 2023 -$9.39M -$2.15M +$1.56M +42% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q2 2023 -$10.9M -$2.19M -$147K -7.18% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024
Q1 2023 -$10.8M -$1.91M +$4.31M +69.3% 01 Jan 2023 31 Mar 2023 10-Q 17 May 2024
Q4 2022 -$15.1M -$3.13M +$3.31M +51.4% 01 Oct 2022 31 Dec 2022 10-K 13 Mar 2024
Q3 2022 -$18.4M -$3.72M -$1.75M -88.6% 01 Jul 2022 30 Sep 2022 10-Q 15 Nov 2023
Q2 2022 -$16.7M -$2.05M -$11.3K -0.56% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 -$16.7M -$6.22M -$4.97M -396% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 -$11.7M -$6.45M -$1.6M -32.9% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 -$10.1M -$1.97M -$681K -52.8% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 -$9.43M -$2.04M -$842K -70.5% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022
Q1 2021 -$8.59M -$1.25M -$81.4K -6.95% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022
Q4 2020 -$8.51M -$4.85M -$3.73M -332% 01 Oct 2020 31 Dec 2020 10-K 31 Mar 2022
Q3 2020 -$4.78M -$1.29M -$174K -15.6% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021
Q2 2020 -$4.6M -$1.19M -$705K -144% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 -$3.9M -$1.17M -$441K -60.3% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021
Q4 2019 -$3.46M -$1.12M +$65.9K +5.54% 01 Oct 2019 31 Dec 2019 10-K 16 Mar 2021
Q3 2019 -$3.52M -$1.12M -$719K -182% 01 Jul 2019 30 Sep 2019 10-Q 17 Nov 2020
Q2 2019 -$2.81M -$489K +$35.6K +6.79% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020
Q1 2019 -$2.84M -$731K -$56.4K -8.36% 01 Jan 2019 31 Mar 2019 10-Q 29 Jun 2020
Q4 2018 -$2.78M -$1.19M -$837K -237% 01 Oct 2018 31 Dec 2018 10-K 15 May 2020
Q3 2018 -$1.95M -$396K +$2.96M +88.2% 01 Jul 2018 30 Sep 2018 10-Q 18 Nov 2019
Q2 2018 -$4.91M -$524K -$335K -177% 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019
Q1 2018 -$4.58M -$674K -$437K -185% 01 Jan 2018 31 Mar 2018 10-Q 28 May 2019
Q4 2017 -$4.14M -$353K -$142K -67.7% 01 Oct 2017 31 Dec 2017 10-KT 13 Apr 2018
Q3 2017 -$4M -$3.36M -$2.76M -462% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 -$1.23M -$189K +$99.6K +34.5% 01 Apr 2017 30 Jun 2017 10-Q 20 Aug 2018
Q1 2017 -$1.33M -$237K +$6.37M +96.4% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018
Q4 2016 -$7.71M -$210K +$3.29M +94% 01 Oct 2016 31 Dec 2016 10-KT 13 Apr 2018
Q3 2016 -$11M -$598K -$282K -89.4% 01 Jul 2016 30 Sep 2016 10-KT 13 Apr 2018
Q2 2016 -$10.7M -$289K -$288K 01 Apr 2016 30 Jun 2016 10-Q 19 Mar 2018
Q1 2016 -$10.4M -$6.61M -$7.73M -691% 01 Jan 2016 31 Mar 2016 10-Q/A 19 Mar 2018
Q4 2015 -$2.7M -$3.5M -$2.47M -240% 01 Oct 2015 31 Dec 2015 10-Q/A 19 Mar 2018
Q3 2015 -$228K -$316K 21 Jul 2015 30 Sep 2015 10-Q 22 Feb 2017
Q2 2015 -$1.5K* -$1.47K 01 Apr 2015 30 Jun 2015 10-Q 19 Aug 2015
Q1 2015 $1.12M +$1.12M 01 Jan 2015 31 Mar 2015 10-Q 05 Jun 2015
Q4 2014 -$1.03M -$1.03M 01 Oct 2014 31 Dec 2014 10-Q 23 Feb 2016
Q2 2014 -$70 -$30* +$19.3K 01 Apr 2014 30 Jun 2014 10-Q 19 Aug 2015
Q1 2014 -$19.4K -$30* +$20.4K 01 Jan 2014 31 Mar 2014 10-Q 05 Jun 2015
Q4 2013 -$39.8K -$10* +$137K 01 Oct 2013 31 Dec 2013 10-Q 17 Apr 2015
Q3 2013 -$177K $0 +$108K 01 Jul 2013 30 Sep 2013 10-K 16 Apr 2015
Q2 2013 -$285K -$19.4K +$226K +92.1% 01 Apr 2013 30 Jun 2013 10-Q 17 Apr 2015
Q1 2013 -$511K -$20.5K +$310K +93.8% 01 Jan 2013 31 Mar 2013 10-Q 17 Apr 2015
Q4 2012 -$822K -$137K +$322K +70.1% 01 Oct 2012 31 Dec 2012 10-Q 17 Apr 2015
Q3 2012 -$1.14M -$108K +$310K +74.1% 01 Jul 2012 30 Sep 2012 10-K 16 Apr 2015
Q2 2012 -$1.45M -$245K +$528K +68.3% 01 Apr 2012 30 Jun 2012 10-Q 16 Apr 2015
Q1 2012 -$1.98M -$331K -$1.84K -0.56% 01 Jan 2012 31 Mar 2012 10-Q 16 Apr 2015
Q4 2011 -$1.98M -$459K -$90.8K -24.7% 01 Oct 2011 31 Dec 2011 10-Q 16 Apr 2015
Q3 2011 -$1.89M -$418K 01 Jul 2011 30 Sep 2011 10-K 15 Apr 2015
Q2 2011 -$773K -$434K -128% 01 Apr 2011 30 Jun 2011 10-Q/A 20 Aug 2012
Q1 2011 -$329K 01 Jan 2011 31 Mar 2011 10-Q 15 May 2012
Q4 2010 -$368K 01 Oct 2010 31 Dec 2010 10-Q 21 Feb 2012
Q2 2010 -$339K 01 Apr 2010 30 Jun 2010 10-Q/A 08 Sep 2011

ABVC BIOPHARMA, INC. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$4.71M +$2.06M +30.5% 01 Jan 2024 31 Dec 2024 10-K 15 Apr 2025
2023 -$6.77M +$8.35M +55.2% 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025
2022 -$15.1M -$3.41M -29.1% 01 Jan 2022 31 Dec 2022 10-K 13 Mar 2024
2021 -$11.7M -$3.2M -37.6% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023
2020 -$8.51M -$5.05M -146% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022
2019 -$3.46M -$674K -24.2% 01 Jan 2019 31 Dec 2019 10-K 16 Mar 2021
2018 -$2.78M +$1.35M +32.7% 01 Jan 2018 31 Dec 2018 10-K 15 May 2020
2017 -$4.14M +$6.86M +62.4% 01 Jan 2017 31 Dec 2017 10-K 15 Apr 2019
2016 -$11M 01 Oct 2015 30 Sep 2016 10-KT 13 Apr 2018
2013 -$177K +$966K +84.5% 01 Oct 2012 30 Sep 2013 10-K 16 Apr 2015
2012 -$1.14M +$745K +39.5% 01 Oct 2011 30 Sep 2012 10-K 16 Apr 2015
2011 -$1.89M +$1.61K +0.09% 01 Oct 2010 30 Sep 2011 10-K 15 Apr 2015
2010 -$1.89M 01 Oct 2009 30 Sep 2010 10-K/A 28 Dec 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.